妊娠期结局与妊娠期糖尿病发生有关:一个队列研究
Samara Souza Stork1, Claudia Meurer Souza1, Josiane Somariva Prophiro1
1Postgraduate Program in Health Sciences, University of Southern Santa Catarina, Tubarão 88704-900, Brazil.
Healthcare (Basel, Switzerland)
|October 16, 2024
概括
孕期糖尿病 (GDM) 显著增加母亲和新生儿的风险,包括分娩并发症和剖腹产. 这种情况也增加了婴儿不良结果的可能性,例如对于妊娠年龄和出生窒息的体重大.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 内分泌学 在内分泌学.
背景情况:
- 孕期糖尿病 (GDM) 是妊娠高血糖的主要原因.
- 在妊娠和产后期间,GDM与母亲和婴儿的并发症有关.
研究的目的:
- 为了调查与GDM发生有关的怀孕结果.
- 分析与GDM相关的母亲和新生儿的风险.
主要方法:
- 在第三个三个月的孕妇被监测到分娩.
- 根据国际糖尿病和怀孕研究小组协会 (IADPSG) 的标准 (血糖≥92 mg/dL) 进行GDM诊断.
主要成果:
- 在138名妇女中,GDM (16.7%) 增加了分娩并发症 (RR 3.40) 和剖腹产 (RR 1.9).
- 没有观察到早产率的显著差异.
- 患有GDM的母亲的婴儿面临更高的风险,比妊娠年龄大 (LGA) (RR 3.29),APGAR分数低 (RR 4.98) 和出生窒息 (RR 9.51).
结论:
- GDM是不良妊娠结果的重要风险因素.
- 调查结果强调了管理GDM对于改善母亲和婴儿健康的重要性.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Pathophysiology of Diabetes
881
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
881
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes: Symptoms, Diagnosis, and Complications
512
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
512
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Oral Hypoglycemic Agents: Biguanides and Glitazones
178
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
178


